Partner with us
Why choose LXO as your partner
We are constantly evolving to anticipate market trends and address patients’ needs.
Through a robust strategy and targeted investments, our revenue and market presence are steadily increasing.
We excel at preserving and enhancing their legacy, ensuring their continuous availability to patients, and contributing to high-quality pharmaceutical solutions essential for public health.
We continuously expand our portfolio to provide our partners with regular opportunities for collaboration and development, supported by a dynamic and high-potential pipeline, backed by the commitment of our main shareholder.
At LXO, we believe that strong collaborations are built on fundamental principles
We aim to push boundaries, innovate to ensure treatment accessibility, and achieve shared goals with determination.
We foster transparent, respectful relationships and act with integrity toward our partners, patients, and the environment.
We uphold high standards in our products, services, and every interaction.
What are the profiles of our partners
We are committed to expanding our global portfolio of branded specialty medicines. Our strategy includes acquiring global or regional rights to established branded products. Our goal is to leverage effective life cycle management, ensuring the continued availability of these products in existing markets while introducing them to new territories.
With our agile platform, we offer sellers a seamless and efficient transfer process. We are dedicated to preserving the legacy of acquired brands and understand that even after a marketing authorization transfer, the brand name remains intrinsically associated with the previous marketing authorization holder in the minds of prescribers.
We collaborate with leading pharmaceutical development companies to deliver medicines to patients worldwide. Our main focus is to license the rights to register and commercialize cardiovascular and neurological products within the EU5 region. Additionally, we aim to expand our pipeline by targeting niche indication products or specialty generics with innovative galenic formulations.
We are seeking specialized pharmaceutical manufacturing partners to optimize our production and ensure high-quality standards. We favor CMOs capable of guaranteeing flexibility, innovative formulation, while promoting European manufacturing to support responsible and sustainable production.
We aim to establish strategic partnerships with CSOs or pharmaceutical laboratories to strengthen our sales force and accelerate our development in key markets. We focus on partners with expertise in pharmaceutical promotion and a strong network among healthcare professionals, while seeking product portfolio synergies.